Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Prolgolimab |
Trade Name | |
Synonyms | BCD-100|BCD100|BCD 100 |
Drug Descriptions |
Prolgolimab (BCD-100) is a monoclonal antibody against PD-1, which may promote anti-tumor immune response (Annals of Oncology, Volume 30, Issue Supplement_11, December 2019, Abstract 119P, PMID: 31847708). |
DrugClasses | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 121 |
CAS Registry Number | 2093956-19-3 |
NCIT ID | C170356 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bevacizumab + Cisplatin + Paclitaxel + Prolgolimab | Bevacizumab Cisplatin Paclitaxel Prolgolimab | 0 | 1 |
Prolgolimab | Prolgolimab | 0 | 0 |